M. Simón-Talero

发表

Impact of ornithine phenylacetate (OCR-002) in lowering plasma ammonia after upper gastrointestinal bleeding in cirrhotic patients

J. A. Arranz, P. Suñé, E. Román, 2016, Therapeutic advances in gastroenterology.

Midodrine and albumin for prevention of complications in patients with cirrhosis awaiting liver transplantation. A randomized placebo-controlled trial.

P. Suñé, M. Pavesi, M. Navasa, 2018, Journal of hepatology.

Hyponatremic and hepatic encephalopathies: similarities, differences and coexistence

J. Córdoba, R. García-Martínez, M. Simón-Talero, 2010, Metabolic Brain Disease.

Embolization of large spontaneous portosystemic shunts for refractory hepatic encephalopathy: A multicenter survey on safety and efficacy

A. Burroughs, F. Nevens, R. Jalan, 2013, Hepatology.

Rapid liver and spleen stiffness improvement in compensated advanced chronic liver disease patients treated with oral antivirals

J. Genescà, R. Esteban, M. Riveiro-Barciela, 2017, Therapeutic advances in gastroenterology.

Minimal hepatic encephalopathy identifies patients at risk of faster cirrhosis progression

C. Montoliu, J. Ampuero, M. Romero-Gómez, 2018, Journal of gastroenterology and hepatology.

Effects of Albumin on Survival after a Hepatic Encephalopathy Episode: Randomized Double-Blind Trial and Meta-Analysis

M. Poca, J. Calleja, J. Genescà, 2021, Journal of clinical medicine.

trends in survival and coronary event rates to changes in coronary ment of Diagnostic and Therapeutic Cardiovascular Procedures heart disease mortality: 10-year results from 37 WHO MONICA (Committee on Percutaneous Transluminal Coronary Angioplasty). J

J. Belda, M. Simón-Talero, J. Merino, 2001 .

Spontaneous portosystemic shunts in liver cirrhosis: new approaches to an old problem

J. Genescà, M. Simón-Talero, S. Quiroga, 2020, Therapeutic advances in gastroenterology.

Covert hepatic encephalopathy and spontaneous portosystemic shunts increase the risk of developing overt hepatic encephalopathy

A. Wienke, J. Trebicka, J. Genescà, 2020, Liver international : official journal of the International Association for the Study of the Liver.

Effects of intravenous albumin in patients with cirrhosis and episodic hepatic encephalopathy: a randomized double-blind study.

J. Sánchez-Delgado, P. Ginès, E. Román, 2013, Journal of hepatology.

Safety of Ornithine Phenylacetate in Cirrhotic Decompensated Patients: An Open-label, Dose-escalating, Single-cohort Study

J. A. Arranz, P. Suñé, J. Córdoba, 2013, Journal of clinical gastroenterology.

Effect of rifaximin on infections, acute‐on‐chronic liver failure and mortality in alcoholic hepatitis: A pilot study (RIFA‐AH)

R. Schwabe, R. Bataller, M. Poca, 2022, Liver international : official journal of the International Association for the Study of the Liver.

Hyperkalemic distal renal tubular acidosis caused by immunosuppressant treatment with tacrolimus in a liver transplant patient: case report.

I. Bilbao, M. Crespo, M. Riveiro-Barciela, 2011, Transplantation proceedings.

Basal values and changes of liver stiffness predict the risk of disease progression in compensated advanced chronic liver disease.

J. Genescà, S. Augustin, M. Pons, 2016, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Congenital Extrahepatic Portosystemic Shunts (Abernethy Malformation): An International Observational Study

F. Nevens, S. Sarin, D. Valla, 2020, Hepatology.

Severe anaemia related to oseltamivir during treatment of chronic hepatitis C: a new drug interaction?

M. Buti, R. Esteban, M. Simón-Talero, 2012, Journal of viral hepatitis.

Sarcoidosis with complications

A. Fernández-Codina, I. Pinal-Fernandez, M. Simón-Talero, 2014, Internal and Emergency Medicine.

Alfapump® system vs. large volume paracentesis for refractory ascites: A multicenter randomized controlled study.

R. Jalan, D. Valla, M. Stepanova, 2017, Journal of hepatology.

ENDPOINTS AND DESIGN OF CLINICAL TRIALS IN PATIENTS WITH DECOMPENSATED CIRRHOSIS: POSITION PAPER OF THE LIVERHOPE CONSORTIUM.

G. Nicolao, A. Forner, P. Kamath, 2020, Journal of hepatology.

A Long-Term Study of Changes in the Volume of Brain Ventricles and White Matter Lesions After Successful Liver Transplantation

F. X. Aymerich, À. Rovira, J. Alonso, 2010, Transplantation.

Vascular diseases of the liver. Clinical Guidelines from the Catalan Society of Digestology and the Spanish Association for the Study of the Liver.

J. Mateo, A. Berzigotti, J. García‐Pagán, 2017 .

Total area of spontaneous portosystemic shunts independently predicts hepatic encephalopathy and mortality in liver cirrhosis.

C. Strassburg, D. Toth, J. Trebicka, 2020, Journal of hepatology.

Association Between Portosystemic Shunts and Increased Complications and Mortality in Patients With Cirrhosis.

D. Toth, J. Trebicka, W. Laleman, 2018, Gastroenterology.

Characteristics, risk factors, and mortality of cirrhotic patients hospitalized for hepatic encephalopathy with and without acute-on-chronic liver failure (ACLF).

M. Pavesi, V. Arroyo, P. Angeli, 2014, Journal of hepatology.

Brain Magnetic Resonance Spectroscopy in Episodic Hepatic Encephalopathy

À. Rovira, J. Alonso, J. Córdoba, 2013, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Epidemiology and Effects of Bacterial Infections in Patients With Cirrhosis Worldwide.

H. Van Vlierberghe, S. Sarin, D. J. Kim, 2019, Gastroenterology.

Liver Transplantation for Porto-sinusoidal Vascular Liver Disorder: Long-term Outcome

A. de Gottardi, F. Nevens, J. Trebicka, 2022, Transplantation.

Hepatic encephalopathy is associated with posttransplant cognitive function and brain volume

À. Rovira, J. Alonso, J. Córdoba, 2011, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Patients with refractory ascites treated with alfapump® system have better health-related quality of life as compared to those treated with large volume paracentesis: the results of a multicenter randomized controlled study

R. Jalan, D. Valla, M. Stepanova, 2018, Quality of Life Research.

Duration of the acute hepatic encephalopathy episode determines survival in cirrhotic patients

J. Ampuero, I. Carmona, J. Genescà, 2017, Therapeutic advances in gastroenterology.

Prognostic Assessment in Patients with Hepatic Encephalopathy

J. Córdoba, R. García-Martínez, M. Simón-Talero, 2011, Disease markers.

Corrigendum to "Alfapump® system vs. large volume paracentesis for refractory ascites: A multicenter randomized controlled study" [J Hepatol 67 (2017) 940-949].

R. Jalan, D. Valla, M. Stepanova, 2018, Journal of Hepatology.

Autoimmune-like hepatitis during masitinib therapy in an amyotrophic lateral sclerosis patient.

J. Camacho, J. Gámez, V. Vargas, 2015, World journal of gastroenterology.

Midodrine and albumin for prevention of complications of cirrhosis in patients in the waiting list for liver transplantation. A randomized, multicenter, double-blind, placebo-controlled trial

P. Suñé, M. Pavesi, J. Castellote, 2017 .